Needham & Company LLC Reaffirms Hold Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “hold” rating reissued by research analysts at Needham & Company LLC in a research report issued to clients and investors on Thursday, Marketbeat reports.

Several other equities research analysts have also recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Mizuho initiated coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price objective for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Trading Up 3.7 %

XRAY opened at $15.56 on Thursday. DENTSPLY SIRONA has a twelve month low of $14.77 and a twelve month high of $33.72. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a fifty day moving average of $18.28 and a 200-day moving average of $20.93. The stock has a market cap of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.52% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Large investors have recently modified their holdings of the business. Nordea Investment Management AB increased its stake in shares of DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. grew its stake in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp grew its stake in DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after acquiring an additional 523,692 shares in the last quarter. Barclays PLC grew its stake in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares in the last quarter. Finally, Canvas Wealth Advisors LLC grew its stake in DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock valued at $6,245,000 after acquiring an additional 182,234 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.